See more : PT Kresna Graha Investama Tbk (KREN.JK) Income Statement Analysis – Financial Results
Complete financial analysis of Sartorius Aktiengesellschaft (SRT3.DE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sartorius Aktiengesellschaft, a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Specificity, Inc. (SPTY) Income Statement Analysis – Financial Results
- Affluence Corporation (AFFU) Income Statement Analysis – Financial Results
- Hangzhou Hota M&E Holdings Co., Ltd. (001225.SZ) Income Statement Analysis – Financial Results
- Ram Ratna Wires Limited (RAMRAT.BO) Income Statement Analysis – Financial Results
- Biomagnetics Diagnostics Corp. (BMGP) Income Statement Analysis – Financial Results
Sartorius Aktiengesellschaft (SRT3.DE)
About Sartorius Aktiengesellschaft
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents. It also provides multi-parallel bioreactors, benchtop bioreactors, single-use bioreactors, stainless steel bioreactors, cell culture bioreactors, microbial bioreactors, and software apps for bioreactors; membranes, blotting products, filter papers, glass and quartz microfibre products, and filtration equipment; syringe filters; and filtration devices, ultrafiltration devices, sterile filtration devices, harvesting devices, analytical sample prep systems, buffer exchange systems, diagnostic sample prep systems, particle analysis systems, pharmaceutical filtration systems, protein DNA concentration systems, venting moisture barriers, clarification systems, buffer and media products, and membrane chromatography products. In addition, the company offers process filtration products; process filtration products; process chromatography products; fluid management products; process analytical technology and data analytics; industrial microbiology systems; water purification systems; weighing systems; pipetting and dispensing systems; OEM systems; and centrifuges. Further, it provides bioprocess development and engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.40B | 4.17B | 3.45B | 2.34B | 1.83B | 1.57B | 1.40B | 1.30B | 1.11B | 891.17M | 887.27M | 845.71M | 733.10M | 659.32M | 602.08M | 611.62M | 589.03M | 521.05M | 484.30M | 467.56M | 442.26M | 476.53M |
| Cost of Revenue | 1.83B | 1.98B | 1.61B | 1.13B | 885.81M | 762.43M | 697.73M | 668.50M | 563.01M | 461.55M | 457.62M | 425.72M | 375.66M | 343.16M | 329.80M | 325.27M | 316.35M | 275.38M | 258.16M | 251.77M | 238.27M | 268.24M |
| Gross Profit | 1.57B | 2.20B | 1.84B | 1.21B | 941.16M | 803.60M | 706.84M | 631.80M | 551.75M | 429.62M | 429.65M | 420.00M | 357.44M | 316.16M | 272.29M | 286.35M | 272.68M | 245.68M | 226.15M | 215.79M | 203.99M | 208.29M |
| Gross Profit Ratio | 46.15% | 52.61% | 53.31% | 51.63% | 51.51% | 51.31% | 50.32% | 48.59% | 49.50% | 48.21% | 48.42% | 49.66% | 48.76% | 47.95% | 45.22% | 46.82% | 46.29% | 47.15% | 46.70% | 46.15% | 46.12% | 43.71% |
| Research & Development | 170.80M | 177.80M | 139.88M | 108.43M | 95.59M | 78.20M | 68.78M | 59.42M | 52.51M | 50.41M | 53.77M | 48.12M | 44.31M | 42.63M | 40.16M | 43.92M | 41.53M | 35.53M | 32.70M | 27.59M | 25.23M | 23.00M |
| General & Administrative | 214.30M | 200.50M | 165.05M | 125.94M | 107.21M | 94.24M | 83.30M | 74.71M | 65.74M | 58.28M | 52.87M | 49.13M | 41.65M | 39.06M | 37.59M | 38.41M | 35.38M | 34.18M | 36.31M | 42.77M | 43.79M | 46.84M |
| Selling & Marketing | 634.40M | 628.50M | 580.68M | 438.72M | 369.68M | 329.83M | 296.84M | 256.61M | 225.89M | 200.22M | 207.09M | 187.50M | 159.52M | 148.53M | 137.46M | 150.23M | 142.59M | 123.48M | -118.79M | -114.10M | -115.21M | -121.76M |
| SG&A | 848.70M | 829.00M | 745.72M | 564.66M | 476.89M | 424.07M | 380.13M | 331.32M | 291.63M | 258.50M | 259.96M | 236.63M | 201.16M | 187.58M | 175.04M | 188.64M | 177.96M | 157.65M | -82.48M | -71.33M | -71.42M | -74.92M |
| Other Expenses | 4.40M | 13.50M | 19.99M | 21.99M | 5.18M | 716.00K | -5.03M | -6.61M | -4.04M | -9.45M | -8.37M | 9.78M | 18.82M | 8.86M | 33.20M | -3.04M | 3.86M | -1.66M | 232.28M | 227.03M | 235.50M | 246.70M |
| Operating Expenses | 1.02B | 1.02B | 905.59M | 695.08M | 577.66M | 502.98M | 443.88M | 384.13M | 340.10M | 299.47M | 305.37M | 294.52M | 264.29M | 239.07M | 248.40M | 229.52M | 223.35M | 191.52M | 182.49M | 183.28M | 189.31M | 194.77M |
| Cost & Expenses | 2.85B | 3.00B | 2.52B | 1.82B | 1.46B | 1.27B | 1.14B | 1.05B | 903.10M | 761.02M | 762.99M | 720.24M | 639.95M | 582.23M | 578.20M | 554.79M | 539.70M | 466.90M | 440.65M | 435.05M | 427.58M | 463.01M |
| Interest Income | 4.60M | 1.00M | 396.00K | 414.00K | 341.00K | 499.00K | 340.00K | 233.00K | 549.00K | 118.00K | 191.00K | 570.00K | 801.00K | 359.00K | 456.00K | 942.00K | 1.04M | 235.00K | 8.63M | 4.83M | 5.40M | 6.45M |
| Interest Expense | 185.40M | 35.20M | 26.92M | 22.27M | 15.95M | 14.51M | 14.55M | 9.53M | 9.73M | 13.16M | 11.71M | 12.37M | 14.90M | 7.17M | 14.07M | 24.60M | 12.36M | 3.29M | 152.00K | 175.00K | 254.00K | 442.00K |
| Depreciation & Amortization | 342.30M | 287.10M | 231.18M | 180.00M | 132.72M | 113.37M | 98.36M | 75.71M | 58.85M | 54.91M | 47.73M | 40.63M | 32.81M | 31.85M | 33.45M | 29.59M | 27.36M | 19.21M | 18.83M | 22.27M | 23.02M | 22.74M |
| EBITDA | 873.10M | 1.54B | 945.12M | 662.13M | 463.53M | 409.18M | 326.22M | 297.21M | 252.59M | 169.56M | 155.12M | 146.25M | 123.89M | 108.22M | 54.32M | 81.04M | 78.31M | 72.09M | 56.38M | 50.30M | 32.80M | 30.70M |
| EBITDA Ratio | 25.71% | 34.09% | 28.03% | 30.14% | 26.74% | 25.87% | 24.87% | 24.71% | 22.80% | 20.85% | 19.33% | 19.36% | 17.29% | 16.41% | 9.60% | 13.25% | 13.29% | 13.84% | 11.18% | 10.76% | 7.42% | 6.44% |
| Operating Income | 543.20M | 1.14B | 735.80M | 523.47M | 355.95M | 300.62M | 262.96M | 247.67M | 211.65M | 130.15M | 124.28M | 125.47M | 93.15M | 77.08M | 23.89M | 56.83M | 49.33M | 54.15M | 43.65M | 32.51M | 14.68M | 13.52M |
| Operating Income Ratio | 16.00% | 27.21% | 21.33% | 22.41% | 19.48% | 19.20% | 18.72% | 19.05% | 18.99% | 14.60% | 14.01% | 14.84% | 12.71% | 11.69% | 3.97% | 9.29% | 8.37% | 10.39% | 9.01% | 6.95% | 3.32% | 2.84% |
| Total Other Income/Expenses | -157.20M | 42.40M | -67.40M | -86.58M | -60.37M | -29.93M | -61.78M | -43.56M | -39.27M | -12.67M | -20.55M | -28.98M | -14.10M | -11.71M | -13.61M | -23.66M | -17.95M | -8.28M | -8.47M | -5.72M | -5.15M | -6.00M |
| Income Before Tax | 386.00M | 1.18B | 668.42M | 446.68M | 303.18M | 270.70M | 198.59M | 204.11M | 172.38M | 96.29M | 101.51M | 96.49M | 79.05M | 62.72M | 10.27M | 26.85M | 41.22M | 45.87M | 35.18M | 27.86M | 9.53M | 7.52M |
| Income Before Tax Ratio | 11.37% | 28.31% | 19.38% | 19.12% | 16.59% | 17.29% | 14.14% | 15.70% | 15.46% | 10.81% | 11.44% | 11.41% | 10.78% | 9.51% | 1.71% | 4.39% | 7.00% | 8.80% | 7.26% | 5.96% | 2.15% | 1.58% |
| Income Tax Expense | 95.90M | 268.60M | 241.45M | 125.21M | 84.43M | 73.22M | 39.26M | 59.10M | 54.99M | 32.38M | 30.87M | 32.24M | 26.25M | 22.03M | 6.24M | 10.57M | 10.92M | 16.85M | 4.83M | 8.14M | 136.00K | -2.49M |
| Net Income | 205.20M | 913.10M | 426.98M | 321.47M | 218.74M | 141.34M | 114.73M | 102.93M | 126.30M | 48.52M | 52.42M | 48.51M | 52.80M | 31.02M | 975.00K | 16.28M | 30.13M | 29.02M | 22.03M | 15.23M | 4.50M | 4.45M |
| Net Income Ratio | 6.04% | 21.87% | 12.38% | 13.76% | 11.97% | 9.03% | 8.17% | 7.92% | 11.33% | 5.44% | 5.91% | 5.74% | 7.20% | 4.70% | 0.16% | 2.66% | 5.12% | 5.57% | 4.55% | 3.26% | 1.02% | 0.93% |
| EPS | 3.00 | 13.35 | 6.24 | 4.70 | 3.20 | 2.07 | 1.67 | 1.50 | 1.85 | 0.71 | 0.77 | 0.71 | 0.61 | 0.46 | -0.11 | 0.18 | 0.44 | 0.43 | 0.33 | 0.22 | 0.07 | 0.06 |
| EPS Diluted | 3.00 | 13.35 | 6.24 | 4.70 | 3.20 | 2.07 | 1.67 | 1.50 | 1.85 | 0.71 | 0.77 | 0.71 | 0.61 | 0.46 | -0.11 | 0.18 | 0.44 | 0.43 | 0.33 | 0.22 | 0.07 | 0.06 |
| Weighted Avg Shares Out | 68.42M | 68.42M | 68.42M | 68.42M | 68.39M | 68.39M | 68.39M | 68.39M | 68.19M | 68.19M | 68.19M | 68.19M | 68.19M | 68.19M | 68.19M | 68.18M | 68.18M | 68.19M | 68.19M | 68.18M | 68.18M | 68.18M |
| Weighted Avg Shares Out (Dil) | 68.42M | 68.42M | 68.42M | 68.42M | 68.39M | 68.39M | 68.39M | 68.39M | 68.19M | 68.19M | 68.19M | 68.19M | 68.19M | 68.19M | 68.19M | 68.18M | 68.18M | 68.19M | 68.19M | 68.18M | 68.18M | 68.18M |
Source: https://incomestatements.info
Category: Stock Reports